Internet Computer ICP

Bitcoin Cash BCH

Litecoin LTC

Loncar China BioPharma ETF

CHNA

Current price

0.081 USD 0 USD (0.00%)

Company –

ISIN US26922A3703

Category China Stock

Exchange NASDAQ

Capitalization 3 720 524 USD

Yield for 12 month –

10Y

15Y

CHNA

21.11.2021 - 28.11.2021

Loncar China BioPharma ETF, a constituent of the ETF, is listed on the NASDAQ. Its market capitalization stands at 3 720 524 USD. The fund's net expense ratio, a critical measure of operational efficiency, is recorded at 0.79 %. A significant allocation in cash assets underscores its liquidity position and risk management strategy. Turning to technical indicators, they offer a granular perspective on the fund's market behavior, historical trends, and potential forward momentum. For further metrics, refer to . For an in-depth analysis get premium access.

Check your investment idea

Find the best to beat the market

TSLA Tesla Motors

AAPL Apple

MSFT Microsoft

Analytics

Total Assets

3 720 524 USD

Net Expense Ratio

0.79 %

Annual Holdings Turnover

27 %

Long 6.83%

Short 6.83%

Net Assets -0%

Long 86.37%

Short -

Net Assets 86.37%

Long 13.63%

Short -

Net Assets 13.63%

Long -

Short -

Net Assets -

Long -

Short -

Net Assets -

1y Volatility 35.21%

Returns YTD 0.00%

3y Volatility 32.68%

Returns 1Y -11.19%

3y ExpReturn 0.00%

Returns 3Y -19.28%

3y SharpRatio -0.53%

Returns 5Y 0.09%

Returns 10Y 0.00%

Dividend growth over 5 years

–

Continuous growth

–

1 year

3 years

5 years

10 years

21.11.2021 - 28.11.2021

0.052 USD 0.11 USD

50 Day MA 14.01 USD

200 Day MA 16.85 USD

	All time	January, 22	February, 22	March, 22	April, 22	May, 22	June, 22
Companies with BMS 90+	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%
Companies with BMS 60-	+10.12%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%	-1.11%

Similar to

Loncar China BioPharma ETF